在Mycobacterium tuberculosis中的内在药物耐受性的变化与家族遗传系相对应
Valerie F A March1,2, Michaela Zwyer1,2, Chloé Loiseau1,2
1Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Antimicrobial agents and chemotherapy
|October 21, 2025
概括
某些Mycobacterium结核病菌系 (L3和L4) 显示出更高的耐药性,可能推动结核病中耐药性的演变. 这种遗传性特征与特定代谢和细胞过程中的突变有关.
科学领域:
- 微生物学 微生物学
- 遗传学 是一个遗传学.
- 药物耐药性研究 药物耐药性研究
背景情况:
- 细菌的耐药性促进了在抗生素暴露期间的生存,有助于药物耐药性的发展.
- 抗药性结核病 (TB) 爆发通常与Mycobacterium tuberculosis (Mtb) 的特定遗传系 (L2和L4) 有关.
研究的目的:
- 为了调查Mtb血统L2和L4表现出更高的内在耐药性,促进更快的药物耐药性演变的假设.
- 量化和比较主要Mtb血统 (L1-L4) 的药物耐受性水平.
主要方法:
- 开发一种高通量体外测定方法来测量Mtb药物耐受性.
- 选择代表全球流行血统 (L1-L4) 的Mtb菌株.
- 在选择的mtb菌株中测量对利芬素和贝达基林的耐受性.
主要成果:
- 与L1和L2菌株相比,来自L3和L4系的菌株对利芬素和贝达基林的耐受性明显更高.
- 在基因学上相关的菌株中观察到类似的耐受性水平,这表明耐药性具有遗传性.
- 高耐受性mtb菌株在与细胞壁/过程,新陈代谢,呼吸和脂质代谢相关的基因中表现出丰富的突变.
结论:
- 在Mtb血统中,内在药物耐受性有所不同,L3和L4更耐受.
- 在Mtb中,遗传性耐药性与特定的遗传突变有关,特别是在代谢和细胞途径中.
- 了解血统特异性耐药性对于解决结核病中耐药性的演变至关重要.
相关概念视频
Dosage Regimen: Individualization
166
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
166
Modern Molecular Taxonomy
580
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
580
Bacterial Phylum Actinobacteria
610
Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
610
Pulmonary Tuberculosis III
924
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
924
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Pulmonary Tuberculosis V
533
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
533


